Investors

Q2 2019

More

CARE and LIVE

Our Annual Report, Corporate Magazine and Company Profile 2018 are now available.

Find out how we unite our vision as a caregiver (CARE) with the wishes of our dialysis patients (LIVE).

.

Learn More
Press release

Underlying business development in line with expectations; Continued strong organic revenue growth; Healthy growth in the U.S. dialysis business

Press release

Fresenius Medical Care is pleased the U.S. Administration’s plans for changing the way care is provided to people with kidney disease supports its existing strategy.

Short News

Fresenius Medical Care North America (FMCNA) has announced an investment in BioIntelliSense, a Denver-based company that is developing a medical grade data services platform for continuous remote...

Fresenius Medical Care Credit Relations

Credit relations

Read more about our main financing instruments, senior notes and the credit ratings.

More
Reporting

Report on 3rd quarter 2019: Earnings Release and Conference Call

Reporting

Quarterly financial report within the 2nd half-year (Q3)

Investor conference

Bernstein Strategic Decision Conference

London
Investor conference

Berenberg & Goldman Sachs German Corporate Conference

Munich
Investor conference

Bank of America Merrill Lynch Global Healthcare Conference

London
Investor conference

Morgan Stanley Global Healthcare Conference

New York